This statistic shows the global revenue of Johnson & Johnson's pharmaceutical segment from 2014 to 2017, by product. In 2016, Remicade was Johnson & Johnson's leading product, generating seven billion U.S. dollars in revenue. Johnson & Johnson is a multinational company, specialized on pharmaceuticals, medical devices and consumer goods. The company is headquartered in New Brunswick, New Jersey.
Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2017 (in million U.S. dollars)
Exclusive Premium Statistic
This statistic shows the global revenue of Johnson & Johnson's pharmaceutical segment from 2014 to 2017, by product. In 2016, Remicade was Johnson & Johnson's leading product, generating seven billion U.S. dollars in revenue. Johnson & Johnson is a multinational company, specialized on pharmaceuticals, medical devices and consumer goods. The company is headquartered in New Brunswick, New Jersey.
| Pharmaceutical product | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
More information
Statistics on "Johnson & Johnson"
Popular Related Keywords
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. top 10 prescribed drugs based on market share 2016
- Americans' impression of the US pharma industry quality of drugs, by ethnicity 2017
- Patented drug 2017 sales share distribution by year of product introduction
- Canada 's global sales share of patented drugs 2005-2016
- Patent drug sales impact on change in expenditure by therapy class in Canada 2017
- Rate of price change for patented drugs 2016, by country
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Sales growth changes of patented drugs in Canada 2017
- 3 year average R&D cost to develop new pharmaceutical compounds 2010-2017
- Number of approved ANDAs in U.S. 2009-2017
- U.S. spending on biosimilars by type 2014
- Average number of ANDAs received per month in U.S. 2009-2017
- R&D cost to develop new pharmaceutical compounds 2010-2017
- Revenues of top diversified products of Valeant Pharmaceuticals U.S. 2017
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- Austria: pharmaceutical goods import value 2012-2017
- manufacture of basic pharmaceutical products revenue in the Netherlands 2010-2022
- manufacture of pharmaceutical preparations revenue in France 2010-2022
- Romania: medicament mixtures not in dosage import value 2012-2016
- manufacture of optical and photographic equipment revenue in Romania 2010-2022
